Accordingly, the NLRP3 inflammasome pathway as well as the resulting production of the master cytokine IL-1ß might contribute to clinically relevant consequences of inflammation in obesity. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.